Home Overview Press Room Blog Publications For Students about us
Search

Personal genomics : Displaying 200-219 of 850


Precision Medicine in Contextby Pete ShanksBiopolitical TimesFebruary 5th, 2015President Obama's proposal for a Precision Medicine Initiative – which echoes President Nixon's "War on Cancer" – should start a conversation that includes lots of questions.
Big Precision Medicine Plan Raises Patient Privacy Concernsby Dina Fine MaronScientific AmericanFebruary 3rd, 2015Tailor-made medicine for patients around the U.S. is getting a boost from a $215-million presidential initiative, but the undertaking is fraught with concerns.
23andMe Only Heightens the Need for Genetic Counsellingby Dr Joyce HarperBioNewsFebruary 2nd, 2015At no point is there any involvement from a physician or genetic counsellor to explain what is being tested for or the consequences of the results.
Millions of DNA Samples Stored in Warehouse Worry Privacy Advocatesby Patrick McGreevyLos Angeles TimesFebruary 1st, 2015The biobank holds blood taken with the prick of a heel from almost every baby born in California for the last three decades.
Obama Thinks "Precision Medicine" Will Make Us Healthier. Experts are Skeptical.by Julia BelluzVoxJanuary 30th, 2015Getting targeted therapies and treatments into the hands of most Americans is much further afield than Obama might like to admit.
U.S. Proposes Effort to Analyze DNA from 1 Million Peopleby Toni Clarke and Sharon BegleyReutersJanuary 30th, 2015At the heart of the "precision medicine" initiative is the creation of a pool of people who would be studied to learn how genetic variants affect health and disease.
Obama Precision Medicine Plan Would Create Huge U.S. Genetic Biobankby Jocelyn KaiserScience InsiderJanuary 29th, 2015The proposed precision medicine initiative would center on a huge new biobank containing medical records and genetic information for perhaps a million Americans.
‘Moonshot’ Medicine Will Let Us Downby Michael J. JoynerThe New York TimesJanuary 29th, 2015President Obama's new budget is expected to include hundreds of millions of dollars for so-called precision medicine. Unfortunately, this is unlikely to make most of us healthier.
Myriad Genetics Ending Patent Dispute on Breast Cancer Risk Testingby Andrew PollackThe New York TimesJanuary 27th, 2015The company has settled or is in the process of settling patent-infringement lawsuits it filed against other companies that now offer such testing.
Genetic Testing and Tribal Identityby Rose EvelethThe AtlanticJanuary 26th, 2015The question of genetic testing, and particularly genetic testing to determine ancestral origins, is controversial for many Native Americans.
Obama to Request Research Funding for Treatments Tailored to Patients’ DNAby Robert PearThe New York TimesJanuary 24th, 2015President Obama will seek hundreds of millions of dollars for a new initiative to develop medical treatments tailored to genetic and other characteristics of individual patients.
Privacy is dead, Harvard professors tell Davos forumAgence France PresseJanuary 22nd, 2015"We are at the dawn of the age of genetic McCarthyism," said one Harvard researcher.
UK Moratorium on Use of Genetic Tests by Insurers Extendedby Philippa BricePHG FoundationJanuary 21st, 2015The purpose of the UK moratorium is similarly to ensure that individuals are not debarred from health or life insurance as a result of genetic testing.
After Canada, UK, 23andMe Wants DNA Test Growth Abroadby Caroline Humer and Christina FarrReutersJanuary 15th, 2015The company, whose consumer-directed tests were barred by U.S. health regulators in 2013, said Western Europe is one focus for expansion.
Direct-to-Consumer Genetic Tests Should Come With a Health Warningby Jessica CussinsThe Pharmaceutical JournalJanuary 15th, 2015Genetic testing is appropriate in certain situations, but for healthy people as a way to predict disease, it is imprecise and comes with a number of risks.
Deals For Genetic Data Raise Issues of Privacy, Sharingby John Lauerman and Makiko KitamuraBloombergJanuary 14th, 2015Big Pharma is making deals to use the personal genetic data accumulated by direct-to-consumer genetic testing companies and others.
23andMe Turns Spit Into Dollars in Deal With Pfizerby Caroline ChenBloombergJanuary 12th, 2015The genetic-testing company backed by Google is sharing DNA data on about 650,000 individuals with Pfizer, the U.S.’s largest drugmaker.
23andMe’s New Formula: Patient Consent = $by Antonio RegaladoMIT Technology ReviewJanuary 6th, 2015How a consumer genetics company amassed a lucrative database of willing research participants.
Most Types of Cancer Largely Down to Bad Luck Rather Than Lifestyle or Genes The Guardian January 1st, 2015Random DNA mutations are largely responsible for two thirds of adult cancers but poor lifestyle can add to the "bad luck factor," according to a new study.
2014 in Biomedicine: Rewriting DNA, Decoding the Brain, and a GMO Paradoxby Antonio RegaladoMIT Technology ReviewDecember 30th, 2014From genetically modified foods to gene therapy, 2014 was a big year for rewriting biology.
Displaying 200-219 of 850  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760